An interventional study of Tele-rehabilitation-guided Qigong in Asthma Childhood, sponsored by Antalya Health Sciences University. Not yet recruiting. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Antalya Health Sciences University · Not applicable, Interventional, and Supportive care
This study investigates the effects of a tele-rehabilitation-guided Qigong exercise program on pulmonary function, functional exercise capacity, and symptom control in children and adolescents with mild-to-moderate asthma.
Participants aged 8 to 18 years will be randomly assigned to either an intervention group or a control group. The intervention group will participate in an 8-week, home-based, tele-rehabilitation-supervised Qigong exercise program in addition to standard medical care. The control group will continue receiving standard medical treatment and routine follow-up.
The primary aim of the study is to evaluate changes in pulmonary function (spirometric parameters such as FEV1 and FVC) and functional exercise capacity measured by the 6-Minute Walk Test (6MWT). Secondary outcomes include asthma symptom control assessed via the Asthma Control Test (ACT/c-ACT) and health-related quality of life.
Pediatric asthma is a prevalent chronic inflammatory airway disease associated with significant morbidity, impaired functional exercise tolerance, and reduced quality of life. While pharmacotherapy represents the cornerstone of management, complementary non-pharmacological interventions, including mind-body exercises, are increasingly recognized for their potential benefits in improving respiratory mechanics and symptom control.
This single-center, randomized controlled clinical trial evaluates the feasibility and therapeutic efficacy of an 8-week tele-rehabilitation-delivered Qigong program in pediatric patients diagnosed with asthma according to GINA guidelines.
Eligible participants will be randomized in a 1:1 ratio into two groups:
Baseline and post-intervention assessments (at week 8) will include spirometry (FEV1, FVC, FEV1/FVC ratio, FEF25-75), functional exercise tolerance evaluated using the standardized 6-Minute Walk Test (6MWT), asthma control level assessed using the Asthma Control Test (ACT) or Childhood Asthma Control Test (c-ACT), and pediatric health-related quality of life scores. Adherence, safety, and adverse events will be monitored throughout the study period.
Antalya Health Sciences University is the lead sponsor of 17 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive an 8-week tele-rehabilitation-supervised Qigong exercise program in addition to standard medical asthma care.
Behavioral: Tele-rehabilitation-guided Qigong
Participants receive standard medical asthma care and routine clinical follow-up without any structured exercise program.
An 8-week home-based Qigong exercise program delivered and supervised via tele-rehabilitation sessions in addition to standard medical asthma care.
Change from Baseline in Forced Expiratory Volume in 1 Second (FEV1)
Assessed by standard spirometry. FEV1 will be measured in liters and reported as percent of predicted value according to international pediatric respiratory guidelines.
Time frame: Baseline and Week 8
Change from Baseline in 6-Minute Walk Distance (6MWD)
Functional exercise capacity evaluated by the standardized 6-Minute Walk Test (6MWT), measuring the total distance walked in meters in 6 minutes.
Time frame: Baseline and Week 8
Change from Baseline in 6-Minute Walk Distance (6MWD)
Assessed using the standardized 6-Minute Walk Test (6MWT). Total distance walked in meters within 6 minutes will be recorded to evaluate functional exercise capacity.
Time frame: Baseline and Week 8
Change from Baseline in Asthma Control Test (ACT) Score
Assessed using the Asthma Control Test (ACT) for adolescents (≥12 years) or Childhood Asthma Control Test (c-ACT) for children (\<12 years). Higher scores indicate better symptom control.
Time frame: Baseline and Week 8
Change from Baseline in Pediatric Asthma Quality of Life Questionnaire (PAQLQ) Score
Assessed via the standardized Pediatric Asthma Quality of Life Questionnaire. Evaluates physical activity limitation, symptoms, and emotional function related to asthma.
Time frame: Baseline and Week 8
No study locations are listed for this record.
Plan to share: Undecided — Individual participant data will not be broadly shared to protect participant confidentiality and privacy in accordance with local institutional ethics regulations and national personal data protection laws. De-identified study data and summary results may be shared upon reasonable request to the corresponding author for valid scientific inquiries.
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Antalya Health Sciences University